Menu
Home
People
Places
Arts
History
Plants & Animals
Science
Life & Culture
Technology
Reference.org
Dexfenfluramine
open-in-new
<h2 id="see-also">See also</h2> <ul><li><a href="/facts/Benfluorex/3F0UA2uz">Benfluorex</a></li> <li><a href="/facts/Fenfluramine/egSpgNxd">Fenfluramine</a></li> <li><a href="/facts/Levofenfluramine/sgmzbaLD">Levofenfluramine</a></li> <li><a href="/facts/Norfenfluramine/kk4YBId6">Norfenfluramine</a></li></ul> <h2 id="external-links">External links</h2> <ul><li><a href="https://web.archive.org/web/20080802021641/http://www.rxlist.com/cgi/generic/dexfen.htm">Drug description</a></li> <li><a href="http://www.inchem.org/documents/pims/pharm/pim939.htm">Dexfenfluramine hydrochloride</a></li> <li><a href="https://web.archive.org/web/19991129023414/http://www.fda.gov/cder/news/phen/fenphenqa2.htm">Questions and Answers about Withdrawal of Fenfluramine (Pondimin) and Dexfenfluramine (Redux)</a></li> <li><a href="https://www.pbs.org/wgbh/pages/frontline/shows/prescription/interviews/lutwak.html">Frontline: Dangerous prescriptions</a>—Interview with Leo Lutwak, M.D. in which he discuses the side effects of fenfluramine, its successor Redux, and the <a href="/facts/Fen-Phen/8UBADHNB">Fen-Phen</a> combination</li></ul> <h2 id="references">References</h2> <ol> <li id="fn:1"><p>Fox SI (2011). Human Physiology (Twelfth ed.). McGraw Hill. p. 665. <a href="#fnref:1" class="footnote-back-ref">↩</a></p></li> <li id="fn:2"><p>Fox SI (2011). Human Physiology (Twelfth ed.). McGraw Hill. p. 665. <a href="#fnref:2" class="footnote-back-ref">↩</a></p></li> <li id="fn:3"><p>FDA 15 September 1997. FDA Announces Withdrawal Fenfluramine and Dexfenfluramine (Fen-Phen) <a href="https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm179871.htm" target="_blank">https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm179871.htm</a> <a href="#fnref:3" class="footnote-back-ref">↩</a></p></li> <li id="fn:4"><p>"Dexfenfluramine". PubChem. U.S. Library of Medicine. Retrieved 29 March 2023. <a href="https://pubchem.ncbi.nlm.nih.gov/compound/66265" target="_blank">https://pubchem.ncbi.nlm.nih.gov/compound/66265</a> <a href="#fnref:4" class="footnote-back-ref">↩</a></p></li> <li id="fn:5"><p>Hanotin C, Thomas F, Jones SP, Leutenegger E, Drouin P (July 1998). "A comparison of sibutramine and dexfenfluramine in the treatment of obesity". Obesity Research. 6 (4): 285–291. doi:10.1002/j.1550-8528.1998.tb00351.x. PMID 9688105. <a href="https://doi.org/10.1002%2Fj.1550-8528.1998.tb00351.x" target="_blank">https://doi.org/10.1002%2Fj.1550-8528.1998.tb00351.x</a> <a href="#fnref:5" class="footnote-back-ref">↩</a></p></li> <li id="fn:6"><p>Lean ME (March 1997). "Sibutramine--a review of clinical efficacy". International Journal of Obesity and Related Metabolic Disorders. 21 (Suppl 1): S30–6, discussion 37–9. PMID 9130039. <a href="https://europepmc.org/article/med/9130039" target="_blank">https://europepmc.org/article/med/9130039</a> <a href="#fnref:6" class="footnote-back-ref">↩</a></p></li> <li id="fn:7"><p>"Abbott Pulls Diet Drug Meridia Off US Shelves". The Wall Street Journal. 8 October 2010. Archived from the original on 23 October 2010. <a href="https://web.archive.org/web/20101023191137/http://online.wsj.com/article/BT-CO-20101008-710904.html" target="_blank">https://web.archive.org/web/20101023191137/http://online.wsj.com/article/BT-CO-20101008-710904.html</a> <a href="#fnref:7" class="footnote-back-ref">↩</a></p></li> <li id="fn:8"><p>Li MF, Cheung BM (February 2011). "Rise and fall of anti-obesity drugs". World Journal of Diabetes. 2 (2): 19–23. doi:10.4239/wjd.v2.i2.19. PMC 3083904. PMID 21537456. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3083904" target="_blank">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3083904</a> <a href="#fnref:8" class="footnote-back-ref">↩</a></p></li> <li id="fn:9"><p>Lemonick MD, Dowell W, Nash JM, Ramirez A, Reid B, Ressner J (23 September 1996). "The New Miracle Drug?". Time. Archived from the original on 6 November 2010. Retrieved 3 October 2010. <a href="/wiki/Michael_Lemonick" target="_blank">/wiki/Michael_Lemonick</a> <a href="#fnref:9" class="footnote-back-ref">↩</a></p></li> <li id="fn:10"><p>Lemonick MD, Nash JM, Park A, Thompson D (29 September 1997). "The Mood Molecule". Time. Archived from the original on 3 October 2008. Retrieved 4 October 2010. <a href="/wiki/Michael_Lemonick" target="_blank">/wiki/Michael_Lemonick</a> <a href="#fnref:10" class="footnote-back-ref">↩</a></p></li> <li id="fn:11"><p>Davis R, Faulds D (November 1996). "Dexfenfluramine. An updated review of its therapeutic use in the management of obesity". Drugs. 52 (5): 696–724. doi:10.2165/00003495-199652050-00007. PMID 9118819. S2CID 261029109. <a href="/wiki/Doi_(identifier)" target="_blank">/wiki/Doi_(identifier)</a> <a href="#fnref:11" class="footnote-back-ref">↩</a></p></li> <li id="fn:12"><p>Philipkoski K (2 March 2004). "DEA Accedes to Ecstasy Test". Wired. Archived from the original on 10 January 2006. <a href="https://web.archive.org/web/20060110115546/https://www.wired.com/news/business/0,1367,62506,00.html" target="_blank">https://web.archive.org/web/20060110115546/https://www.wired.com/news/business/0,1367,62506,00.html</a> <a href="#fnref:12" class="footnote-back-ref">↩</a></p></li> </ol>